Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactions

D. H. Moon, J. M. Lee, A. M. Noonan, C. M. Annunziata, L. Minasian, N. Houston, J. L. Hays, E. C. Kohn

Research output: Contribution to journal › Article › peer-review